Literature DB >> 8841835

Increased migration of neutrophils to granulocyte-colony stimulating factor in rat carrageenin-induced pleurisy: roles of complement, bradykinin, and inducible cyclooxygenase-2.

M Ogino1, M Majima, M Kawamura, K Hatanaka, M Saito, Y Harada, M Katori.   

Abstract

Administration of human recombinant granulocyte colony-stimulating factor (G-CSF, 100 micrograms/kg/day, s.c) to rats for 4 days significantly increased circulating neutrophil counts (by 1130%), together with an increase in mononuclear leukocyte counts (by 119%). Infiltrated pleural neutrophil counts in G-CSF-treated rats (G-CSF-r) 5 h after the intrapleural injection of zymosan-activated serum were significantly higher (by 155%) than those in control rats (Vehicle-r). In carrageenin-induced pleurisy, counts of infiltrated pleural neutrophils in G-CSF-r 5 and 7 h after carrageenin were significantly higher (by 119% and 116%) than those in Vehicle-r. G-CSF treatment increased the volume of pleural exudate and the plasma exudation rate by 122% and 226%, compared to values in Vehicle-r 5 h after carrageenin. Cobra venom factor (75 micrograms/kg, i.v.) significantly reduced pleural neutrophil migration in G-CSF-r (by 53%) and Vehicle-r (by 49%). Bromelain (10 mg/kg, i.v.) and aspirin (100 mg/kg, p.o.) reduced pleural neutrophil migration and reduced exudate volume and plasma exudation. Intrapleural bradykinin-(1-5) and prostaglandin E2 levels were significantly higher in G-CSF-r than in Vehicle-r. The increased neutrophil migration in G-CSF-r may be attributed to enhanced activation of the complement system facilitated by increased plasma exudation due to bradykinin and prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841835     DOI: 10.1007/bf02252946

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  33 in total

1.  A significant role of plasma kallikrein-kinin system in plasma exudation of rat carrageenin-induced pleurisy.

Authors:  M Katori; M Majima; Y Harada; A Ueno
Journal:  Adv Exp Med Biol       Date:  1989       Impact factor: 2.622

2.  Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine.

Authors:  M Di Rosa; J P Giroud; D A Willoughby
Journal:  J Pathol       Date:  1971-05       Impact factor: 7.996

3.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

4.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

Authors:  M Ballow; C G Cochrane
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

5.  Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease.

Authors:  T Oda; Y Kojima; T Akaike; S Ijiri; A Molla; H Maeda
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

6.  Sequential appearance of IL-1 and IL-6 activities in rat carrageenin-induced pleurisy.

Authors:  I Utsunomiya; S Nagai; S Oh-ishi
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

7.  Biphasic accumulation of leukocytes in rat cardiac infarct tissue caused by leukotriene B4 and complement.

Authors:  M Katori; T Kanayama; K Sasaki; A Ueno; M Takagi; S Yamashina
Journal:  Jpn J Pharmacol       Date:  1989-06

8.  A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma.

Authors:  C Shima; M Majima; M Katori
Journal:  Jpn J Pharmacol       Date:  1992-10

9.  Release of endogenous prostaglandins by mild hyperosmotic saline inhibits tetragastrin-stimulated gastric acid secretion in rats.

Authors:  Y Suzuki; Y Harada; A Ueno; M Katori; H Okabe
Journal:  Prostaglandins       Date:  1986-09

10.  Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.

Authors:  M H Bronchud; J H Scarffe; N Thatcher; D Crowther; L M Souza; N K Alton; N G Testa; T M Dexter
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

View more
  7 in total

1.  Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403.

Authors:  D Salvemini; E Mazzon; L Dugo; D P Riley; I Serraino; A P Caputi; S Cuzzocrea
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

2.  Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro.

Authors:  Jane E Onken; Paula K Greer; Brian Calingaert; Laura P Hale
Journal:  Clin Immunol       Date:  2007-12-21       Impact factor: 3.969

3.  Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats.

Authors:  Caroline Bélanger; Hanan Elimam; Julie Lefebvre; Pierre Borgeat; Sylvie Marleau
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

4.  Bromelain treatment decreases neutrophil migration to sites of inflammation.

Authors:  David J Fitzhugh; Siqing Shan; Mark W Dewhirst; Laura P Hale
Journal:  Clin Immunol       Date:  2008-05-14       Impact factor: 3.969

5.  Pharmacological characterisation of arthritis induced by Bothrops jararaca venom in rabbits: a positive cross talk between bradykinin, nitric oxide and prostaglandin E2.

Authors:  Suzana B V Mello; Maria Luiza Guzzo; Luiz Filipe Santiago Lisboa; Sandra H P Farsky
Journal:  Mediators Inflamm       Date:  2002-02       Impact factor: 4.711

6.  Plant proteolytic enzyme papain abrogates angiogenic activation of human umbilical vein endothelial cells (HUVEC) in vitro.

Authors:  Thomas Mohr; Lucia Desser
Journal:  BMC Complement Altern Med       Date:  2013-09-21       Impact factor: 3.659

7.  Enhancement of the Anti-inflammatory Effect of Bromelain by Its Immobilization on Probiotic Spore of Bacillus cereus.

Authors:  Chika Jude Ugwuodo; Tochukwu Nwamaka T Nwagu; Tochukwu Thaddeus Ugwu; Chukwudi Ogbonnaya Onwosi
Journal:  Probiotics Antimicrob Proteins       Date:  2020-11-06       Impact factor: 4.609

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.